Inventor

M. Amin Khan

Inventor
Evanston, IL, US

Overview

28→
Patents
2012–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides7%
Y02PClimate change mitigation technologies in the production or processing of goods7%
C12MApparatus for enzymology or microbiology4%
C12NMicroorganisms or enzymes4%
LOC241%
PatentTitleYear
10,441,572Spiro-lactam NMDA receptor modulators and uses thereof201910,441,571Spiro-lactam NMDA receptor modulators and uses thereof201910,316,041Spiro-lactam NMDA receptor modulators and uses thereof201910,273,239Spiro-lactam NMDA receptor modulators and uses thereof201910,253,032Spiro-lactam NMDA receptor modulators and uses thereof201910,195,179Spiro-lactam NMDA receptor modulators and uses thereof201910,196,401Spiro-lactam NMDA receptor modulators and uses thereof201910,179,898Bioreactor for the cultivation of mammalian cells201910,150,769Spiro-lactam NMDA modulators and methods of using same201810,052,308Spiro-lactam NMDA receptor modulators and uses thereof20189,994,614N-methyl-D-aspartate receptor modulators and methods of making and using same20189,932,347Spiro-lactam NMDA receptor modulators and uses thereof20189,925,169'Spiro-lactam NMDA receptor modulators and uses thereof'20189,828,384Spiro-lactam NMDA receptor modulators and uses thereof20179,802,946'NMDA receptor modulators and uses thereof'20179,783,771'Three bioreactor system for the cultivation of mammalian cells'20179,758,525'Spiro-lactam NMDA receptor modulators and uses thereof'20179,738,650'Spiro-lactam NMDA receptor modulators and uses thereof'20179,708,335'Spiro-lactam NMDA receptor modulators and uses thereof'20179,670,446'Bioreactor for the cultivation of mammalian cells'20179,593,145'Secondary structure stabilized NMDA receptor modulators and uses thereof'20179,579,304'Spiro-lactam NMDA receptor modulators and uses thereof'20179,512,133'NMDA receptor modulators and uses thereof'20169,512,134'Spiro-lactam NMDA receptor modulators and uses thereof'20169,504,670'Spiro-lactam NMDA receptor modulators and uses thereof'20169,101,612'Secondary structure stabilized NMDA receptor modulators and uses thereof'20158,673,843'NMDA receptors modulators and uses thereof'2014D0664262'Impeller arrangement for fermenter'2012

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2012Based in Hertfordshire, GB· patent location history
2014–2017Patents assigned to UNIV NORTHWESTERN (5)· patent assignee history
2014–2019Based in Evanston, IL, US· patent location history
2016–2019Patents assigned to APTINYX INC (17)· patent assignee history
2016–2017Patents assigned to Aptinyx Incorporated (2)· patent assignee history
2017–2019Patents assigned to LONZA BIOLOGICS PLC (3)· patent assignee history
2017–2019Patents assigned to APYTINYX INC (2)· patent assignee history
2017–2019Based in Watford, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
APTINYX INC172016–2019
UNIV NORTHWESTERN52014–2017
LONZA BIOLOGICS PLC32017–2019
APYTINYX INC22017–2019
Aptinyx Incorporated22016–2017
Locations
LocationPatentsSpan
Evanston, Illinois, US242014–2019
Watford, GB32017–2019
Hertfordshire, GB12012